| ［1］Conlon JM, Yano K, Waugh D, et al. Distribution and molecular forms of urotensinⅡ and its role in cardiovascular regulationin vertebrates［J］. J Exp Zool, 1996, 275(2/3):226-238.
［2］Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning of the cDNA encoding the urotensinⅡ precursor in frog and human reveals intense expression of the urotensinⅡgene in moto neurons of thes pinal cord ［J］. Proc Natl Acad Sci USA, 1998, 95(26):15803-15808.
［3］丁波, 陈志武, 高杉. 人UrotensinⅡ对大鼠急性心肌缺血及缺血再灌注损伤的保护作用［J］. 安徽医科大学学报, 2006, 41(5):556-559.
［4］Chen ZW, Yang Q, Huang Y, et al. Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery ［J］. Vas Pharmacol, 2010, 52(1/2): 70-76.
［5］姜丽红，吴成哲. 冠心舒通胶囊对急性心肌梗死大鼠缺血心肌血管新生的影响［J］. 长春中医药大学学报, 2015, 31(3): 451-454.
［6］Zhang JY, Chen ZW, Yao H. Protective effect of urantide against ischemia-reperfusion injury via protein kinase C and phosphtidylinositol 3'-kinase-Akt pathway ［J］. Can J Physiol Pharmacol, 2012, 90(5): 637-645.
［7］Zhang JH, Chen ZW, Wu Z. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury ［J］. Can J Physiol Pharmacol, 2008, 86: 131-138.
［8］王荣俊, 丁波, 文继月, 等. 人urotensinⅡ对大鼠心肌细胞缺氧-再给氧损伤的保护作用及机制［J］. 中国临床药理学与治疗学, 2016, 21(12): 1341-1346.
［9］Ames RS, Sarau HM, Chambers JK, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 ［J］. Nature, 1999, 401(6750): 282-286.
［10］Xu WM, Liu LZ. Nitric oxide: from a mysterious labile factor to the molecule of the Nobel Prize. Recent progress in nitric oxide research ［J］. Cell Res, 1998, 8(4): 251-258.
［11］许丹, 刘昌慧. 尾加压素Ⅱ对人脐静脉内皮细胞iNOS表达的影响［J］. 中国应用生理学杂志, 2006, 22(3): 288-291. |
